Literature DB >> 6458564

Evidence for two distinct populations of suppressor cells in the spleens of Mycobacterium bovis BCG-Sensitized mice.

R Turcotte.   

Abstract

Spleen cells from female C57BL/6 mice infected intravenously with 1 mg (about 10(7) viable units) of bacillus Calmette-Guérin (BCG) were shown to suppress the blastogenic responses induced by the T-cell mitogens phytohemagglutinin and concanavalin A and by the B-cell mitogen lipopolysaccharide in spleen cells from normal syngeneic mice. By using various separation procedures or cellular treatments, evidence was found for two distinct populations of splenic suppressor cells. One population belonged to the monocyte-macrophage lineage on the basis of their adherence to plastic surfaces, their removal after treatment with carbonyl iron, and their resistance to gamma irradiation. The other population of suppressor cells belonged to the T lymphocytes due to their sensitivity to an anti-Thy 1 antiserum and complement and to gamma irradiation. After separation on nylon wool columns, inhibitory activity was found in both the nonadherent and the adherent spleen cell populations. Both populations of suppressor cells were present in the spleens 14 days after BCG inoculation and persisted for at least 40 days after infection.

Entities:  

Mesh:

Year:  1981        PMID: 6458564      PMCID: PMC350866          DOI: 10.1128/iai.34.2.315-322.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Suppressor T-cells in BCG-infected mice.

Authors:  F M Collins; S R Watson
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

2.  Inhibition of mitogen and immune blastogenesis by two distinct populations of supressor cells present in the spleens of fibrosarcoma-bearing mice: adoptive transfer of suppression.

Authors:  W L Farrar; K D Elgert
Journal:  Int J Cancer       Date:  1978-08-15       Impact factor: 7.396

3.  BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro.

Authors:  G R Klimpel; C S Henney
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

4.  Two distinct populations of suppressor cells in the spleens of mice bearing methylcholanthrene-induced tumors.

Authors:  B L Pope; R B Whitney; J G Levy
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability.

Authors:  C A Brown; I N Brown; V S Sljivić
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

6.  Suppression of phytohemagglutinin and lipopolysaccharide responses in mouse spleen cells by Bacillus Calmette-Guerin.

Authors:  E M Allen; V L Moore
Journal:  J Reticuloendothel Soc       Date:  1979-10

7.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

8.  Suppression of spleen natural killing activity induced by BCG.

Authors:  M Ito; P Ralph; M A Moore
Journal:  Clin Immunol Immunopathol       Date:  1980-05

9.  Infection with Bacillus Calmette-Guérin activates murine thymus-independent (B) lymphocytes.

Authors:  B M Sultzer
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

10.  Opposite effects of BCG on spleen and lymph node cells: lymphocyte proliferation and immunoglobulin synthesis.

Authors:  R Turcotte; L Lafleur; M Labrèche
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

View more
  18 in total

1.  Patterns of IL-2 production and utilization in mice heavily infected with Mycobacterium bovis BCG reflect the phase of protective immunity being expressed.

Authors:  E S Miller; I M Orme
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

2.  Capacity of murine T cells to retain long-term responsiveness to mycobacterial antigens is controlled by the H-2 complex.

Authors:  A V Pichugin; S V Khaidukov; A M Moroz; A S Apt
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Induction by an immunogenic immunomodulating agent of nonspecific T cell suppression of lymphocyte responsiveness in MLR but not of antibody production.

Authors:  C Reuben; D Halperin; S Ben-Efraim; D W Weiss
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Mechanisms underlying the depressed production of interleukin-2 in spleen and lymph node cell cultures of mice infected with Mycobacterium bovis BCG.

Authors:  R Turcotte; D Legault
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

5.  Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.

Authors:  L Mellow; E Sabbadini
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

6.  Survival of Mycobacterium lepraemurium in C57BL mice after acquired protective immunity.

Authors:  M Løvik; O Closs
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

7.  Immune response to atypical mycobacteria: immunocompetence of heavily infected mice measured in vivo fails to substantiate immunosuppression data obtained in vitro.

Authors:  I M Orme; F M Collins
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

8.  Variables which affect suppression of the immune response induced by Pseudomonas aeruginosa exotoxin A.

Authors:  P S Holt; M L Misfeldt
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

9.  In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.

Authors:  V Colizzi
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

10.  Blastogenic responses of lymphocytes from mice immunized by sublethal infection with yeast cells of Histoplasma capsulatum.

Authors:  R P Tewari; N Khardori; P McConnachie; L A von Behren; T Yamada
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.